BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28434530)

  • 1. Accelerated cellular senescence as underlying mechanism for functionally impaired bone marrow-derived progenitor cells in ischemic heart disease.
    Nollet E; Hoymans VY; Rodrigus IR; De Bock D; Dom M; Van Hoof VOM; Vrints CJ; Van Craenenbroeck EM
    Atherosclerosis; 2017 May; 260():138-146. PubMed ID: 28434530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone Marrow-Derived Progenitor Cells Are Functionally Impaired in Ischemic Heart Disease.
    Nollet E; Hoymans VY; Rodrigus IR; De Bock D; Dom M; Vanassche B; Van Hoof VO; Cools N; Van Ackeren K; Wouters K; Vermeulen K; Vrints CJ; Van Craenenbroeck EM
    J Cardiovasc Transl Res; 2016 Aug; 9(4):266-78. PubMed ID: 27456951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
    Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between the frequency of CD34⁺ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes.
    Bozdag-Turan I; Turan RG; Turan CH; Ludovicy S; Akin I; Kische S; Arsoy NS; Schneider H; Ortak J; Rehders T; Hermann T; Paranskaya L; Kohlschein P; Bastian M; Ulus AT; Sahin K; Ince H; Nienaber CA
    Cardiovasc Diabetol; 2011 Nov; 10():107. PubMed ID: 22118372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease.
    Turan RG; Bozdag-T I; Ortak J; Kische S; Akin I; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Belu C; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
    Stem Cell Rev Rep; 2011 Sep; 7(3):646-56. PubMed ID: 21188654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired mobilization of CD133(+) bone marrow-derived circulating progenitor cells with an increased number of diseased coronary arteries in ischemic heart disease patients with diabetes.
    Turan RG; Turan CH; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Kleinfeldt T; Rehders TC; Rauchhaus M; Adolph E; Amen S; Hermann T; Yokus S; Brehm M; Steiner S; Sahin K; Nienaber CA; Ince H
    Circ J; 2011; 75(11):2635-41. PubMed ID: 21828932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease.
    Turan RG; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Adolph E; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
    Stem Cells Dev; 2011 Sep; 20(9):1491-501. PubMed ID: 21190450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of dyskeratosis congenita.
    Beier F; Foronda M; Martinez P; Blasco MA
    Blood; 2012 Oct; 120(15):2990-3000. PubMed ID: 22932806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell contact accelerates replicative senescence of human mesenchymal stem cells independent of telomere shortening and p53 activation: roles of Ras and oxidative stress.
    Ho JH; Chen YF; Ma WH; Tseng TC; Chen MH; Lee OK
    Cell Transplant; 2011; 20(8):1209-20. PubMed ID: 21176396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the functional impairment of bone marrow-derived circulating progenitor cells and the extend of coronary artery disease.
    Bozdag-Turan I; Turan RG; Paranskaya L; Arsoy NS; Turan CH; Akin I; Kische S; Ortak J; Schneider H; Ludovicy S; Hermann T; D'Ancona G; Durdu S; Akar AR; Ince H; Nienaber CA
    J Transl Med; 2012 Jul; 10():143. PubMed ID: 22776510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment.
    Tamarat R; Silvestre JS; Le Ricousse-Roussanne S; Barateau V; Lecomte-Raclet L; Clergue M; Duriez M; Tobelem G; Lévy BI
    Am J Pathol; 2004 Feb; 164(2):457-66. PubMed ID: 14742252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autologous bone marrow mononuclear cells and peripheral endothelial progenitor cells differentiation in myocardial ischemia reperfusion injury region in swine].
    Li CJ; Gao RL; Yang YJ; Song LF; Ruan YM; Hu FH; Yang WX; Chen JL; Qiao SB; Qin XW; Liu YQ; Chen ZJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):350-3. PubMed ID: 17711663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow-derived myocyte-like cells and regulation of repair-related cytokines after bone marrow cell transplantation.
    Misao Y; Takemura G; Arai M; Sato S; Suzuki K; Miyata S; Kosai K; Minatoguchi S; Fujiwara T; Fujiwara H
    Cardiovasc Res; 2006 Feb; 69(2):476-90. PubMed ID: 16368087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleostemin rejuvenates cardiac progenitor cells and antagonizes myocardial aging.
    Hariharan N; Quijada P; Mohsin S; Joyo A; Samse K; Monsanto M; De La Torre A; Avitabile D; Ormachea L; McGregor MJ; Tsai EJ; Sussman MA
    J Am Coll Cardiol; 2015 Jan; 65(2):133-47. PubMed ID: 25593054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.
    Li SR; Qi XY; Hu FL; Zhang JQ; Wang TH; Dang Y; Meng CL; Liu HL; Li YX; Wu D; Dong J; Xun LY; Gao LH; Jin FC
    Chin Med J (Engl); 2008 Dec; 121(23):2403-9. PubMed ID: 19102957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated senescence in the bone marrow mesenchymal stem cells of acquired aplastic anemia patients: A possible implication of DNA damage responses and telomere attrition.
    Saxena P; Srivastava J; Rai B; Tripathy NK; Raza S; Sinha RA; Gupta R; Yadav S; Nityanand S; Chaturvedi CP
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167025. PubMed ID: 38237741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem-cell senescence and myocardial repair - Coronary artery disease genotype/phenotype analysis of post-MI myocardial regeneration response induced by CABG/CD133+ bone marrow hematopoietic stem cell treatment in RCT PERFECT Phase 3.
    Wolfien M; Klatt D; Salybekov AA; Ii M; Komatsu-Horii M; Gaebel R; Philippou-Massier J; Schrinner E; Akimaru H; Akimaru E; David R; Garbade J; Gummert J; Haverich A; Hennig H; Iwasaki H; Kaminski A; Kawamoto A; Klopsch C; Kowallick JT; Krebs S; Nesteruk J; Reichenspurner H; Ritter C; Stamm C; Tani-Yokoyama A; Blum H; Wolkenhauer O; Schambach A; Asahara T; Steinhoff G
    EBioMedicine; 2020 Jul; 57():102862. PubMed ID: 32629392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone Marrow Is a Reservoir for Cardiac Resident Stem Cells.
    Liu N; Qi X; Han Z; Liang L; Kong D; Han Z; Zhao S; He ZX; Li Z
    Sci Rep; 2016 Jun; 6():28739. PubMed ID: 27345618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial.
    Taylor DA; Perin EC; Willerson JT; Zierold C; Resende M; Carlson M; Nestor B; Wise E; Orozco A; Pepine CJ; Henry TD; Ellis SG; Zhao DX; Traverse JH; Cooke JP; Schutt RC; Bhatnagar A; Grant MB; Lai D; Johnstone BH; Sayre SL; Moyé L; Ebert RF; Bolli R; Simari RD; Cogle CR;
    Cell Transplant; 2016; 25(9):1675-1687. PubMed ID: 26590374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectinemia controls pro-angiogenic cell therapy.
    Eren P; Camus S; Matrone G; Ebrahimian TG; François D; Tedgui A; Sébastien Silvestre J; Blanc-Brude OP
    Stem Cells; 2009 Nov; 27(11):2712-21. PubMed ID: 19785008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.